XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Treasury stock
Noncontrolling interest in consolidated subsidiaries
Increase (Decrease) in Shareholders' Equity              
Impact of ASC 842 adoption $ 1,175,738 $ 27,900 $ 0 $ 2,067,811 $ (303,185) $ (692,549) $ 75,761
Beginning balance at Dec. 29, 2018 1,175,738 27,900 0 2,067,811 (303,185) (692,549) 75,761
Increase (Decrease) in Shareholders' Equity              
Impact of ASC 842 adoption 1,165,174 27,900 0 2,067,811 (303,185) (692,549) 75,761
Net earnings 77,746     75,823     1,923
Other comprehensive income (loss) 282       113   169
Cash dividends declared (16,339)     (16,339)      
Dividends to noncontrolling interests (4,459)           (4,459)
Purchase of noncontrolling interest (27,845)   277       (28,122)
Purchase of treasury shares, shares acquired (38,350)         (38,350)  
Stock plan exercises, shares acquired (827)         (827)  
Stock options exercised 1,744   (5,242) 5,345   1,641  
Stock option expense 1,456   1,456        
Stock awards 4,914   3,509     1,405  
Ending balance at Jun. 29, 2019 1,165,174 27,900 0 2,123,754 [1] (303,072) (728,680) 45,272
Increase (Decrease) in Shareholders' Equity              
Impact of ASC 842 adoption 1,171,053 27,900 0 2,089,276 [1] (298,740) (700,333) 52,950
Beginning balance at Mar. 30, 2019 1,171,053 27,900 0 2,089,276 [1] (298,740) (700,333) 52,950
Increase (Decrease) in Shareholders' Equity              
Impact of ASC 842 adoption 1,165,174 27,900 0 2,123,754 [1] (303,072) (728,680) 45,272
Net earnings 40,668     39,719     949
Other comprehensive income (loss) (4,298)       (4,332)   34
Cash dividends declared (8,126)     (8,126)      
Dividends to noncontrolling interests (3,621)           (3,621)
Purchase of noncontrolling interest (4,763)   277       (5,040)
Purchase of treasury shares, shares acquired (28,929)         (28,929)  
Stock plan exercises, shares acquired (80)         (80)  
Stock options exercised 570   (2,575) 2,885   260  
Stock option expense 728   728        
Stock awards 1,972   1,570     402  
Ending balance at Jun. 29, 2019 1,165,174 27,900 0 2,123,754 [1] (303,072) (728,680) 45,272
Increase (Decrease) in Shareholders' Equity              
Impact of ASC 842 adoption 1,165,174 27,900 0 2,123,754 [1] (303,072) (728,680) 45,272
Impact of ASC 842 adoption 1,189,745 27,900 0 2,173,802 (313,422) (743,942) 45,407
Beginning balance at Dec. 28, 2019 1,189,745 27,900 0 2,173,802 (313,422) (743,942) 45,407
Increase (Decrease) in Shareholders' Equity              
Impact of ASC 842 adoption 1,152,702 27,900 0 2,194,916 (332,486) (763,495) 25,867
Net earnings 65,475     65,536     (61)
Other comprehensive income (loss) (18,576)       (19,064)   488
Cash dividends declared (19,223)     (19,223)      
Dividends to noncontrolling interests (5,642)           (5,642)
Purchase of noncontrolling interest (50,111)   0 (30,661)     (19,450)
Addition of noncontrolling interest 5,125           5,125
Purchase of treasury shares, shares acquired (20,481)         (20,481)  
Stock plan exercises, shares acquired (5)         (5)  
Stock options exercised 724   (5,217) 5,462   479  
Stock option expense 1,223   1,223        
Stock awards 4,448   3,994     454  
Ending balance at Jun. 27, 2020 1,152,702 27,900 0 2,194,916 (332,486) (763,495) 25,867
Increase (Decrease) in Shareholders' Equity              
Impact of ASC 842 adoption 1,110,130 27,900 0 2,171,329 [1] (347,868) (763,950) 22,719
Beginning balance at Mar. 28, 2020 1,110,130 27,900 0 2,171,329 [1] (347,868) (763,950) 22,719
Increase (Decrease) in Shareholders' Equity              
Impact of ASC 842 adoption 1,152,702 27,900 0 2,194,916 (332,486) (763,495) 25,867
Net earnings 22,754     22,607     147
Other comprehensive income (loss) 15,365       15,382   (17)
Cash dividends declared (9,598)     (9,598)      
Dividends to noncontrolling interests (300)           (300)
Purchase of noncontrolling interest 7,818   0 8,025     (207)
Addition of noncontrolling interest 3,525           3,525
Stock plan exercises, shares acquired (2)         (2)  
Stock options exercised 664   (2,206) 2,553   317  
Stock option expense 612   612        
Stock awards 1,734   1,594     140  
Ending balance at Jun. 27, 2020 1,152,702 27,900 0 2,194,916 (332,486) (763,495) 25,867
Increase (Decrease) in Shareholders' Equity              
Impact of ASC 842 adoption $ 1,152,702 $ 27,900 $ 0 $ 2,194,916 $ (332,486) $ (763,495) $ 25,867
[1] The retained earnings balance has been revised from the amounts previously reported as a result of the change in inventory valuation method from     LIFO to FIFO. Refer to Note 1 for additional information.